{"ticker": {"uuid": "e5264b51-e7e3-4291-a966-81a284f565cb", "symbol": "002620", "name": "Jeil Pharma Holdings Inc", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Price to book forward of JEIL PHARMA HOLDINGS INC. \u2013 KRX:002620", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOeWNIQVdtRlh4WjVlTDFmcWY3Z0RRZEd2Sy10UktBM2NQWDNneFZJYjg1eTY3Ynl1RmJFNk1XNUZvVTVhR253MGJINGhsTml1TGhFQ3RNMk1pZko5aThubm44b25oek1reVFwRzV2SnYwZjVQRjNLQ2F6SUN6cEUtSlRkMTc1S2pYdVE4Rkxyb2lkMUktdm9neEMzbw?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T02:47:01+00:00", "published_display": "13 Jul 2026 02:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of JEIL PHARMA HOLDINGS INC. \u2013 KRX:002620", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPYUs4eEhnX3lpRDJUWkZuM1JydmRYeUlOLXczai1iT1hNNURMdkRsNmRwOHFsT3J0dXJCdXJyQ0V6cXZUQnlTbHpPeVloQ2hheHZiVEctLWo4QzF3MG9udjhwT29TT096X0s4TjVlZmpzVGxLN3pFNjk0TGJ6WjhpNklaVU96WnNzUS1GamMybFVRcUEtRmptZGMyeTJnNE9KNGd2Nld3?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T01:27:21+00:00", "published_display": "13 Jul 2026 01:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Han Sang-cheol becomes co-CEO of JEIL PHARMACEUTICAL alongside Seong Seok-je - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcHVacjh5UTFnRmdOZ3cwZFFMZkxfTUZuU3Y0YUFUclFNV3JzeUlxcXlqMDhuelBZZGdfNzRBVS05X3k5bnJqZ0o0Z3pVSHRfQmRpWXVlSnJ2TGhETzJrRWFQT3F2MXd5MXMyZzNRWVJ6SUJ3b2ZmV3M4UmhjQ2s5OdIBlAFBVV95cUxPRkx1akU4TVNzT1BMZ2FyUE9BRFNKZ3d1ODM5MWZvOWxCdUF3Q0d4QW9HbC1LZHJIUGJhLVdSY3h2cENyZ0twaW0zY0p1c1BfeUNya0pTWVo0cUJVeXZBd0I3bEd1TU1rZk5sZk5FWXZlM3B0enJyb1hsb2w0Tm9OdXpNOW42M2VBa1dZSW9HUVlxRkZs?oc=5", "source_name": "Chosunbiz", "published_at": "2025-03-25T07:00:00+00:00", "published_display": "25 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viatris, Jeil Pharma to launch dyslipidemia compound in May", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBtQnpWQTlnRU1xdnIyaEpFSE13NEF0N2ZQZF9jM3pfRWxMaHJNYzJ3WW5FWWJrZnVsOFNYTjJTaTJ4VDA2UldvLTkyZlFIeUVuVE01WWJqMDZKdDc2cE5HQnFGdEZDTlNUVDFkLVR30gFyQVVfeXFMT0FiS0pVQ2FtbXNqTWdIY3ZIU1hhd2pQV0hncy0tMlI3S2FLSGtXTHNNQ045UUJ1SHFvTlpxWkpfT0VLYkJvRnViMEtGd2lNWG1ONWZDSVBqdWZwMnlRWEdabERSTXJLSnFsRk9SdXdhb0Z3?oc=5", "source_name": "koreabiomed.com", "published_at": "2021-04-27T07:00:00+00:00", "published_display": "27 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of JEIL PHARMA HOLDINGS INC. \u2013 KRX:002620", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOeWNIQVdtRlh4WjVlTDFmcWY3Z0RRZEd2Sy10UktBM2NQWDNneFZJYjg1eTY3Ynl1RmJFNk1XNUZvVTVhR253MGJINGhsTml1TGhFQ3RNMk1pZko5aThubm44b25oek1reVFwRzV2SnYwZjVQRjNLQ2F6SUN6cEUtSlRkMTc1S2pYdVE4Rkxyb2lkMUktdm9neEMzbw?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T02:47:01+00:00", "published_display": "13 Jul 2026 02:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of JEIL PHARMA HOLDINGS INC. \u2013 KRX:002620", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPYUs4eEhnX3lpRDJUWkZuM1JydmRYeUlOLXczai1iT1hNNURMdkRsNmRwOHFsT3J0dXJCdXJyQ0V6cXZUQnlTbHpPeVloQ2hheHZiVEctLWo4QzF3MG9udjhwT29TT096X0s4TjVlZmpzVGxLN3pFNjk0TGJ6WjhpNklaVU96WnNzUS1GamMybFVRcUEtRmptZGMyeTJnNE9KNGd2Nld3?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T01:27:21+00:00", "published_display": "13 Jul 2026 01:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Han Sang-cheol becomes co-CEO of JEIL PHARMACEUTICAL alongside Seong Seok-je - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcHVacjh5UTFnRmdOZ3cwZFFMZkxfTUZuU3Y0YUFUclFNV3JzeUlxcXlqMDhuelBZZGdfNzRBVS05X3k5bnJqZ0o0Z3pVSHRfQmRpWXVlSnJ2TGhETzJrRWFQT3F2MXd5MXMyZzNRWVJ6SUJ3b2ZmV3M4UmhjQ2s5OdIBlAFBVV95cUxPRkx1akU4TVNzT1BMZ2FyUE9BRFNKZ3d1ODM5MWZvOWxCdUF3Q0d4QW9HbC1LZHJIUGJhLVdSY3h2cENyZ0twaW0zY0p1c1BfeUNya0pTWVo0cUJVeXZBd0I3bEd1TU1rZk5sZk5FWXZlM3B0enJyb1hsb2w0Tm9OdXpNOW42M2VBa1dZSW9HUVlxRkZs?oc=5", "source_name": "Chosunbiz", "published_at": "2025-03-25T07:00:00+00:00", "published_display": "25 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viatris, Jeil Pharma to launch dyslipidemia compound in May", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBtQnpWQTlnRU1xdnIyaEpFSE13NEF0N2ZQZF9jM3pfRWxMaHJNYzJ3WW5FWWJrZnVsOFNYTjJTaTJ4VDA2UldvLTkyZlFIeUVuVE01WWJqMDZKdDc2cE5HQnFGdEZDTlNUVDFkLVR30gFyQVVfeXFMT0FiS0pVQ2FtbXNqTWdIY3ZIU1hhd2pQV0hncy0tMlI3S2FLSGtXTHNNQ045UUJ1SHFvTlpxWkpfT0VLYkJvRnViMEtGd2lNWG1ONWZDSVBqdWZwMnlRWEdabERSTXJLSnFsRk9SdXdhb0Z3?oc=5", "source_name": "koreabiomed.com", "published_at": "2021-04-27T07:00:00+00:00", "published_display": "27 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 40, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 6680.0, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": -6.6, "twelve_week_move": -25.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.317865, "market_dynamics_buy_signal": false, "relative_strength": -50.581737, "fair_value_gap": -26.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.6633, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, -6.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Chosunbiz", "count": 1}, {"label": "koreabiomed.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.4% over one week, -6.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of JEIL PHARMA HOLDINGS INC. \u2013 KRX:002620"}], "updated_at": "2026-07-18T01:55:33.526149+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}